This randomized open-label trial compared the efficacy and tolerability of vortioxetine (15 mg/daily) with different antidepressants in the treatment of patients with Burning Mouth Syndrome (BMS).
Vortioxetine versus other antidepressants in the treatment of Burning Mouth Syndrome: an open-label randomized trial / Adamo, D., Pecoraro, G., Coppola, N., Calabria, E., Aria, M., Mignogna, M.D.. - In: ORAL DISEASES. - ISSN 1354-523X. - 27:4(2021), pp. 1022-1041. [10.1111/odi.13602]
Vortioxetine versus other antidepressants in the treatment of Burning Mouth Syndrome: an open-label randomized trial
Coppola, Noemi;Calabria, Elena
;Aria, Massimo;Mignogna, Michele Davide
2021
Abstract
This randomized open-label trial compared the efficacy and tolerability of vortioxetine (15 mg/daily) with different antidepressants in the treatment of patients with Burning Mouth Syndrome (BMS).File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
23.pdf
accesso aperto
Licenza:
Dominio pubblico
Dimensione
1.31 MB
Formato
Adobe PDF
|
1.31 MB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
